Randomized controlled trial comparing radiotherapy plus /- endocrine therapy versus endocrine therapy alone for PSA failure after radical prostatectomy: Japan Clinical Oncology Group Study JCOG0401

被引：0
|
作者：
Yokomizo, A. [1 ]
Satoh, T. [2 ]
Hashine, K. [3 ]
Inoue, T. [4 ]
Fujimoto, K. [5 ]
Egawa, S. [6 ]
Habuchi, T. [7 ]
Kawashima, K. [8 ]
Ishizuka, O. [9 ]
Shinohara, N. [10 ]
Sugimoto, M. [11 ]
Yoshino, Y. [12 ]
Wakabayashi, M. [13 ]
Nihei, K. [14 ]
Fukuda, H. [13 ]
Tobisu, K-I. [15 ]
Kakehi, Y.
Naito, S. [1 ]
机构：
[1] Harasanshin Hosp, Urol, Fukuoka, Japan
[2] Kitasato Univ, Urol, Sch Med, Sagamihara, Kanagawa, Japan
[3] Natl Hosp Org, Urol, Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[4] Kyoto Univ, Urol, Kyoto, Japan
[5] Nara Med Univ, Urol, Nara, Japan
[6] Jikei Univ Hosp, Urol, Tokyo, Japan
[7] Akita Univ, Urol, Grad Sch Med, Akita, Japan
[8] Tochigi Canc Ctr, Urol, Utsunomiya, Tochigi, Japan
[9] Shinshu Univ, Urol, Sch Med, Matsumoto, Japan
[10] Hokkaido Univ Hosp, Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan
[11] Kagawa Univ, Urol, Fac Med, Takamatsu, Kagawa, Japan
[12] Nagoya Univ, Urol, Grad Sch Med, Nagoya, Aichi, Japan
[13] Natl Canc Ctr, JCOG Data Ctr, Operat Off, Tokyo, Japan
[14] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Radiat Oncol, Tokyo, Japan
[15] Komagome Hosp, Urol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
788PD
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a Japan Clinical Oncology Group Study (JCOG9401)
    Shien, Tadahiko
    Iwata, Hiroji
    Aogi, Kenjiro
    Fukutomi, Takashi
    Inoue, Kenichi
    Kinoshita, Takayuki
    Takahashi, Masato
    Matsui, Akira
    Shibata, Taro
    Fukuda, Haruhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (06) : 982 - 988
  • [32] Protocol digest of randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan clinical oncology group study (JCOG1407)
    Mizusawa, Junki
    Fukutomi, Akira
    Katayama, Hiroshi
    Ishii, Hiroshi
    Ioka, Tatsuya
    Okusaka, Takuji
    Ueno, Hideki
    Ueno, Makoto
    Ikeda, Masafumi
    Mizuno, Nobumasa
    Ozaka, Masato
    Fukuda, Haruhiko
    Furuse, Junji
    PANCREATOLOGY, 2018, 18 (07) : 841 - 845
  • [33] Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)
    Morizane, Chigusa
    Okusaka, Takuji
    Mizusawa, Junki
    Takashima, Atsuo
    Ueno, Makoto
    Ikeda, Masafumi
    Hamamoto, Yasuo
    Ishii, Hiroshi
    Boku, Narikazu
    Furuse, Junji
    CANCER SCIENCE, 2013, 104 (09): : 1211 - 1216
  • [34] A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage is carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A gynecologic oncology group study
    Sedlis, A
    Bundy, BN
    Rotman, MZ
    Lentz, SS
    Muderspach, LI
    Zaino, RJ
    GYNECOLOGIC ONCOLOGY, 1999, 73 (02) : 177 - 183
  • [35] Comment on 'Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)'
    Nagano, H.
    BRITISH JOURNAL OF CANCER, 2013, 109 (09) : 2505 - 2505
  • [36] Comment on ‘Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)’
    H Nagano
    British Journal of Cancer, 2013, 109 : 2505 - 2505
  • [37] A randomized, phase III trial of paclitaxel plus carboplatin (TC) versus paclitaxel plus cisplatin (TP) in stage IVb, persistent or recurrent cervical cancer: Japan Clinical Oncology Group study (JCOG0505)
    Kitagawa, Ryo
    Katsumata, Noriyuki
    Shibata, Taro
    Nakanishi, Toru
    Nishimura, Sadako
    Ushijima, Kimio
    Takano, Masashi
    Satoh, Toyomi
    Yoshikawa, Hiroyuki
    Kamura, Toshiharu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] A phase III randomized controlled trial comparing surgery plus adjuvant chemotherapy with preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for locally recurrent rectal cancer: Japan Clinical Oncology Group study JCOG1801 (RC-SURVIVE study)
    Kadota, Tomohiro
    Tsukada, Yuichiro
    Ito, Masaaki
    Katayama, Hiroshi
    Mizusawa, Junki
    Nakamura, Naoki
    Ito, Yoshinori
    Bando, Hideaki
    Ando, Masahiko
    Onaya, Hiroaki
    Fukuda, Haruhiko
    Kanemitsu, Yukihide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (08) : 953 - 957
  • [39] A Randomized Controlled Trial of the Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients with Colorectal Cancer: Japan Clinical Oncology Group Study JCOG1006
    Takii, Yasumasa
    Shimada, Yasuhiro
    Moriya, Yoshihiro
    Nakamura, Kenichi
    Katayama, Hiroshi
    Kimura, Aya
    Shibata, Taro
    Fukuda, Haruhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (01) : 97 - 100
  • [40] Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial
    Solberg, Arne
    Widmark, Anders
    Tasdemir, Ilker
    Ahlgren, Goran
    Angelsen, Anders
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2011, 45 (04): : 233 - 238
12345